Invasive listeriosis in Denmark 1994–2003: a review of 299 cases with special emphasis on risk factors for mortality  by Gerner-Smidt, P. et al.
ORIGINAL ARTICLE 10.1111/j.1469-0691.2005.01171.x
Invasive listeriosis in Denmark 1994–2003: a review of 299 cases with
special emphasis on risk factors for mortality
P. Gerner-Smidt, S. Ethelberg, P. Schiellerup, J. J. Christensen, J. Engberg, V. Fussing, A. Jensen,
C. Jensen, A. M. Petersen and B. G. Bruun
Danish Reference Centre for Listeriosis, Statens Serum Institut, Copenhagen, Denmark
ABSTRACT
Listeriosis is a rare, but serious, foodborne infection which, in the invasive form, presents as
bloodstream (BS) infection, an infection of the central nervous system (CNS), a maternofetal infection or
a focal infection. The disease is notifiable in Denmark. This paper reviews the results of the Danish
surveillance of invasive listeriosis from 1994 to 2003, excluding maternofetal cases. In total, 299 invasive
cases of listeriosis were reported. Two-thirds of the cases were caused by isolates of serogroup 1 ⁄ 2, and
one-third by serogroup 4. Most (70%) cases had conditions known to predispose to listeriosis. More
patients with BS infection were predisposed because of concurrent underlying illness than were patients
with CNS infection. Half of the patients were aged > 70 years, and 21% died of the disease. There was no
change in the case fatality rate (CFR) during the 10-year period. The CFR was identical for men and
women. BS and CNS infection caused the same incidence of mortality, but no mortality was observed in
patients with focal infections at normally sterile body sites. In a multivariate analysis, isolates belonging
to serogroup 4 were associated with a higher CFR than were isolates of serogroup 1 ⁄ 2. In patients aged
< 70 years, underlying conditions predisposing to disease were related strongly to mortality, which was
not the case in patients aged > 70 years. The underlying conditions associated most strongly with
mortality in the younger age group were non-haematological malignancies.
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INTRODUCTION
Listeriosis is a foodborne disease caused by the
Gram-positive bacterium Listeria monocytogenes.
This organism occurs ubiquitously in nature, and
it is therefore not possible to eliminate it totally
from raw produce or ready-to-eat products that
have been prepared without a bacterial inactivat-
ing step, e.g., heat treatment. Consequently,
humans are exposed regularly to Listeria. Consid-
ering the high exposure rate, the pathogenicity of
the organism must be low, as listeriosis is a rare
disease, with an annual incidence in most coun-
tries of < 1 ⁄ 100 000 inhabitants [1]. However,
when Listeria causes disease, it is usually severe
with a high case fatality rate (CFR) of 20–50% [2].
The disease has three major clinical presentations,
i.e., bloodstream (BS) infection, infection of the
central nervous system (CNS), and maternofetal
listeriosis, which is a systemic infection transmit-
ted from the mother to the neonate before or
during birth. Less severe presentations, such as
cutaneous listeriosis and infectious gastroenter-
itis, also occur [3,4], but these presentations are
rarely reported to surveillance systems or in the
scientific literature.
Certain conditions have been identified as risk-
factors for severe invasive listeriosis, including
the extremes of age, malignancies, diabetes mell-
itus, alcoholism, liver disease and other immuno-
suppressing diseases and treatments [5–9]. The
major host defence against listeriosis is cell-
mediated immunity, and therefore individuals
with T-cell dysfunction seem to be particularly at
risk of contracting the disease [10,11]. In addition
to host factors, pathogen-specific factors also
seem to be important in causing disease. Three
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serotypes of L. monocytogenes, 1 ⁄ 2a, 1 ⁄ 2b, and 4b,
cause > 95% of cases in humans [2]. Most isolates
from food belong to serogroup 1 ⁄ 2 [12–14], but
most outbreaks of human disease are caused by
strains of serotype 4b, whereas serogroup 1 ⁄ 2
strains predominate in cases of sporadic listeriosis
[2]. This indicates that serotype 4b strains may be
more pathogenic for humans than strains of other
serotypes.
In the present study, cases of invasive listeriosis
identified by the Danish surveillance system were
reviewed for the period 1994–2003. As the epi-
demiology of maternofetal listeriosis differs from
the non-pregnancy-related presentations [2,15],
such cases were excluded. A comprehensive
study of risk-factors for mortality resulting from
listeriosis has not been published previously.
Therefore, a multivariate analysis of possible
risk-factors available in the Danish listeriosis
surveillance database was performed.
MATERIALS AND METHODS
Culture-confirmed cases of listeriosis have been subject to
mandatory notification by Danish diagnostic laboratories to
the Listeria Reference Centre at Statens Serum Institut since
1993. Only the age, sex, isolation site, collection date of the
diagnostic specimen and hospital department from which the
specimen was sent are notifiable. All non-neonatal cases of
listeriosis involving isolation of L. monocytogenes from a
normally sterile site were included.
Most diagnostic laboratories also submit the infecting
isolate to the reference laboratory on a voluntary basis for
confirmation and subtyping. At the same time, information
regarding the clinical presentation, underlying disease,
immunosuppressive treatment, current antibiotic therapy,
and the general condition of the patient, including survival,
was also reported. If this information was missing or
incomplete, the reference centre contacted the submitting
laboratory in order to obtain as much information as possible.
Cases that were diagnosed by blood culture only were
registered as BS infections unless the clinical condition was
stated clearly as meningitis and ⁄ or encephalitis. Cases in
which Listeria was isolated from cerebrospinal fluid were
registered as CNS infections. If the patient was in a critical
condition at the time of contact, the outcome was checked
1 month after the initial isolation of Listeria. All surviving
patients at that point were considered to have survived the
infection; those who had died were recorded as having had
listeriosis as at least a contributing factor leading to death.
Identification of isolates was confirmed in the reference
laboratory by standard methods [16], followed by serogroup-
ing with antisera (Difco; Becton Dickinson, Brøndby,
Denmark) according to the recommendations of the manu-
facturer.
Statistical analyses were performed using SAS software
v. 8.2 (SAS Institute, Cary, NC, USA). The multivariate logistic
regression model was built by trying all combinations of
available variables and eliminating those that were either not
significant at the 95% level or were confounding other
variables, with subsequent tests for statistical interactions.
RESULTS
Basic demographic results
In total, 299 invasive episodes of listeriosis (164 in
males and 135 in females) were reported in 298
patients; 221 presented with BS infection, 71 with
CNS infection and seven with focal infections at
normally sterile body sites (bones, joints and
peritoneum). The annual incidence of disease in
Denmark ranged from 0.42 to 0.75 ⁄ 100 000 inhab-
itants, peaking in 1999 (Fig. 1). Geographically,
patients were distributed evenly, and there was
no clear seasonal trend in the occurrence of
disease. No general outbreaks of invasive disease
were detected during the study period. The age
distribution of all patients and those who died is
shown in Fig. 2, along with the general age
distribution of the Danish population. There was
an obvious association between increased age and
the risk of invasive listeriosis. Nine patients were
found in the lowest age group (< 10 years); these
patients were aged 1–7 years and had no known
predisposing conditions, except for the oldest
patient, a boy aged 7 years with diabetes. Seven of
these patients had BS infections.
Isolates were received from 294 cases. Of these,
174 belonged to serogroup 1 ⁄ 2, 118 belonged to
serogroup 4, and two did not belong to either.
The serogroup 1 ⁄ 2:4 ratio did not change during
the study period. There was a trend towards
patients infected with serogroup 4 isolates pre-
senting with a CNS infection rather than a BS
infection (data not shown). Information about
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Fig. 1. Annual number of cases of invasive listeriosis in
Denmark, 1994–2003. The group ‘Other’ denotes focal
infections (arthritis ⁄ osteitis ⁄peritonitis ⁄pleuritis). BS,
bloodstream; CNS, central nervous system.
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well-known risk-factors for listeriosis was avail-
able for 275 cases, with predisposing conditions
existing in 192 cases (Table 1).
Predisposing conditions were divided into six
subgroups: haematological malignancies; non-
haematological malignancies; immunosuppres-
sive therapy; alcoholism; diabetes mellitus; and
others. The last group was a diverse group
containing patients with chronic liver disease,
chronic renal insufficiency, inflammatory bowel
disease, autoimmune disease, multiple sclerosis
or AIDS. More than one predisposing condition
was recorded for 89 patients. The fraction of
predisposed patients was larger in the group of
patients with BS infection (157 ⁄ 200; 78%) than in
those with CNS infection (30 ⁄ 68; 44%)
(p < 0.001; Fisher’s exact test, two-tailed). One
patient, a male aged 78 years suffering from
multiple myeloma, developed two episodes of
BS infection, separated by 8 months, with
isolates belonging to different serogroups. The
patient survived both infections.
Three infections were probably hospital-
acquired. The patients (three males aged 56, 65
and 79 years, respectively) were unrelated and
had been in hospital for 1.5–2 months before
developing a Listeria BS infection. The first suf-
fered from end-stage malignant melanoma trea-
ted with prednisone, the second suffered from
alcoholism, and the third received cytostatic
treatment for a lymphoma. The first patient died,
with Listeria infection as a contributing factor.
Mortality
Sixty-four (21%; 34 males) patients died within a
month of diagnosis of their disease. The CFR was
20.8% (46 ⁄ 221) in the BS infection group and
25.4% (18 ⁄ 71) in the CNS infection group (p > 0.5;
Fisher’s exact test, two-tailed). No deaths
occurred in the group of patients with focal
infections. Nationwide, there was no change in
the CFR during the 10-year period. The results of
the univariate analysis are shown in Table 2.
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Fig. 2. Age distribution of listeriosis patients and the
Danish population in general.
Table 1. Predisposing factors, sex distribution and age
distribution of patients with bloodstream or central ner-
vous system listeriosis
Disease category Cases
Males
(%)
Median
age
CNS ⁄BS
infection
Alcoholism 29 22 (76) 59 11 ⁄ 18 (38%)a
Diabetes mellitus 21 12 (55) 74 7 ⁄ 14 (33%)
Haematological malignancy 54 31 (57) 69 7 ⁄ 47 (13%)
Non-haematological malignancies 39 21 (54) 65 1 ⁄ 38 (3%)
Immunosuppressive treatment 79 44 (56) 68 11 ⁄ 68 (14%)
Other underlying disease 60 35 (58) 67 12 ⁄ 48 (25%)
No underlying disease 81 37 (46) 76 38 ⁄ 43 (47%)
All casesb 268 147 (55) 69 68 ⁄ 200 (34%)
CNS, central nervous system; BS, bloodstream.
aPercentage of CNS infections among patients in the specified disease category.
bOnly cases for which information about predisposing factors was available.
Table 2. Frequency and relative risks for death from
listeriosis by univariate analysis
Determinant
No. of
patients
No. who
died Risk
RR
(95% CI)
Serogroup (n = 292)
1 ⁄ 2 174 30 0.17 1 (reference)
4 118 32 0.27 1.6 (0.97–2.6)
Gender (n = 299)
Female 164 34 0.21 1
Male 135 30 0.22 1.0 (0.61–1.6)
Clinical picture (n = 292)
BS infection 221 46 0.21 1
CNS infection 71 18 0.25 1.2 (0.70–2.1)
Predisposed (n = 275)
No 83 14 0.17 1
Yes 192 42 0.22 1.3 (0.70–2.4)
Alcoholism
No 244 47 0.19 1
Yes 31 9 0.29 1.5 (0.74–3.1)
Diabetes
No 253 50 0.20 1
Yes 22 6 0.27 1.35 (0.58–3.1)
Haematological malignancies
No 221 49 0.22 1
Yes 54 7 0.13 0.59 (0.27–1.3)
Non-haematological malignancies
No 236 42 0.18 1
Yes 39 14 0.36 2.0 (1.1–3.7)
Immunosuppressive treatment
No 196 43 0.22 1
Yes 79 13 0.16 0.72 (0.34–1.3)
Other underlying disease
No 213 44 0.21 1
Yes 62 12 0.19 0.90 (0.48–1.7)
Age (years) (n = 299)
< 70 147 28 0.19 1
‡ 70 152 36 0.24 1.2 (0.73–2.0)
RR, relative risk.
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Infection with a serogroup 4 isolate was a
risk-factor for death from listeriosis. Of the
host-related risk-factors, only underlying non-
haematological malignancy was associated with
a significantly higher risk of death. Advanced age
was associated moderately with death, and there
was only one death among previously healthy
listeriosis patients aged < 70 years.
Table 3 shows the multivariate main effects
logistic regression model, based on the 270
patients for whom data on all variables were
available. Three variables, i.e., serogroup, age and
predisposition, were selected, and a statistically
significant interaction between age and predispo-
sition was detected in the model (p 0.02). Infec-
tion with a serogroup 4 isolate remained
associated in the model with an increased CFR.
The association between CFR and any condition
predisposing to listeriosis was dependent on age.
Such conditions were associated with an in-
creased CFR in patients aged < 70 years, but not
above this age. An age > 70 years was associated
with an increased CFR, irrespective of the predis-
posing conditions. Considering each condition
predisposing to disease separately, non-haemato-
logical malignancy remained the only significant
risk-factor for mortality (odds ratio (OR) 3.6, 95%
CI 1.5–8.5). Alcoholism, diabetes mellitus and the
group of other immunosuppressing diseases had
a non-significant association with an OR >1
(alcoholism, OR 2.0, 95% CI 0.8–5.2; diabetes
mellitus, OR 2.2, 95% CI 0.8–6.1; other diseases,
OR 1.7, 95% CI 0.7–4.0).
DISCUSSION
A 10-year cohort of invasive listeriosis in
Denmark was examined. The overall CFR was
21%, and several determinants of a fatal outcome
were noted in a multivariate analysis of available
variables. Infection with an isolate belonging to
serogroup 4 (as opposed to serogroup 1 ⁄ 2) carried
an increased risk of mortality, irrespective of age.
This indicates that serogroup 4 isolates are more
virulent than those of serogroup 1 ⁄ 2. This is
in line with the observation that serotype 4b
isolates cause infection more frequently in previ-
ously healthy individuals than do serogroup 1 ⁄ 2
isolates [17], and that serotype 4b is over-repre-
sented among isolates from humans, compared
with food sources where serogroup 1 ⁄ 2 isolates
predominate [12–14]. However, the increased
virulence of serogroup 4 isolates observed in the
present study might be related also to the genetic
lineage and not just the serotype. Using molecular
methods, it is possible to subdivide the species
into three major phylogenetic lineages [18,19]. All
isolates of the same serotype fall into the same
lineage; thus 4b isolates are within one lineage,
together with serotype 1 ⁄ 2b and some other rare
serotypes; another lineage contains serotype 1 ⁄ 2a
and some rarer serotypes; and the remaining rare
serotypes are in a third lineage [20]. However,
because the isolates were typed only by O-group,
and not by flagellar type, it is not known whether
the serotype 1 ⁄ 2b isolates are as virulent as the 4b
isolates, as would be expected if virulence is
related to genetic lineage rather than the serotype.
Since 1997, all isolates have also been subtyped by
automated ribotyping. Some ribopatterns, mostly
of isolates belonging to serogroup 4, were asso-
ciated with increased patient mortality (data not
shown).
Overall, age was not a statistically significant
risk-factor, but was an effect modifier of the risk
associated with underlying illness. Among the
patients aged < 70 years, a condition known to
predispose to listeriosis was an important risk-
factor for mortality. This was not the case for
patients aged > 70 years, whose risk of mortality
was independent of other conditions. The analysis
focused on the patient-related risk-factors that are
known to predispose to illness, but only non-
haematological malignancy was a significant risk-
factor in the multivariate analysis. Surprisingly,
haematological malignancies, which predispose
most strongly to disease [6,7,21], were not among
the high risk-factors for death from listeriosis (OR
0.96, 95% CI 0.36–2.53). A possible explanation is
that this patient group is always in close contact
with the health system and is treated promptly
Table 3. Frequency and odds ratios for death from listeri-
osis by multivariate model
Determinant Patients No. of deaths Odds ratio 95% CI
Serogroup 1 ⁄ 2 160 25 1 (reference)
Serogroup 4 110 29 2.1 1.1–3.9
Patient not predisposed,
age < 70 years
29 1 1 (ref)
Patient predisposed,
age < 70 years
107 26 10.3 1.3–80
Patient not predisposed,
age ‡ 70 years
51 11 8.0 0.98–66
Patient predisposed,
age ‡ 70 years
83 16 7.7 0.96–61
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with antibiotics in case of fever. Increased
mortality from listeriosis in patients with chronic
kidney disease has been noted [22]. This was not
confirmed in the present study; one of five
patients with renal transplants died, as did one
of eight non-transplant patients with chronic
renal insufficiency (data not shown).
It was hardly surprising that underlying disease
or immunosuppressive conditions or treatment
were risk-factors for death from listeriosis in the
younger age group. It was also expected that old
age per se might predispose to death from listeri-
osis. However, it was surprising that underlying
disease or other immunocompromising condi-
tions did not increase the CFR in the older age
group. One possible explanation is that the level
of immunosuppression in patients with predis-
posing conditions causing an increased CFR in
the younger patients is also achieved in older
patients simply by the general debility and, more
specifically, by the T-cell dysfunction, that comes
with old age [23]. However, this finding could be
an artefact, either because underlying disease is
common in the older age group and might be
present without being diagnosed, or because the
underlying illnesses and treatments in the young-
er patients might have caused greater immuno-
suppression than in the older age group. Autopsy
reports and more detailed information from the
patient files would have been helpful in clarifying
this point, but were not available for the present
study.
The incidence of listeriosis in Denmark peaked
in 1999 at 0.75 cases ⁄ 100 000 inhabitants, and
declined to 0.46 cases ⁄ 100 000 inhabitants in 2003
(Fig. 1). This incidence is still high compared
with the frequencies reported from other Euro-
pean countries [24]. However, it is difficult to
make a direct comparison of the rates because
surveillance systems differ between countries
[25]. Compared with historical Danish data, the
CNS:BS infection ratio seems to have decreased
since the 1980s. During that period [26], the ratio
was c. 1:1 among non-outbreak cases, and was
2:3 in 1989–1990 [6]. During the present 10-year
period, there has been a general trend towards a
decrease in this ratio (declining to 1:5 in 2003).
However, the total number of sporadic listeriosis
cases has increased since reporting of the disease
became mandatory in 1993. This increase has
been observed mainly in the number of patients
diagnosed with BS infection, while the number of
cases with CNS infection has remained constant
since the 1980s, with an average of seven cases
annually. Increased awareness of listeriosis in
laboratories as a consequence of mandatory
reporting, combined with more efficient blood
culture systems, and a tendency of clinicians to
take more blood cultures, probably explains this
finding.
The ratio between the infecting serogroups
seems to have inverted since the 1980s, with
two-thirds of isolates now belonging to serogroup
1 ⁄ 2. However, two large outbreaks occurred in
1985–1987 [26] and in 1989–1991 [6]. Both were
caused by a serogroup 4 strain, and the serogroup
ratio of the sporadic cases has not changed if this
is taken into account.
Most (70%) cases presented with a known risk-
factor for listeriosis, excluding age. This agrees
with previous observations in Denmark and
elsewhere [1,6,26,27]. If old age (> 70 years) is
considered as a risk-factor for the disease, the
percentage of patients with risk-factors increases
to c. 90%. As observed in previous studies
[7–9,26], patients who were previously healthy
presented more frequently with a CNS infection
than with a BS infection, while the opposite was
found in patients with predisposing conditions. It
has been suggested that bacteraemia is more
likely to be diagnosed in patients with underlying
conditions because this patient group is monit-
ored closely with blood cultures, whereas mild
cases of bacteraemia, e.g., influenza-like disease,
are likely to remain undetected in otherwise
healthy individuals [7]. The clinical symptoms
of CNS infection are consistently severe, and
patients suffering from this condition are more
likely to come into contact with the health system,
irrespective of underlying conditions.
One patient in the present study was infected
with isolates of different serogroups at an interval
of 8 months. Such re-infections are rare, but have
been described previously [6,28]. Three of the
infections described here were probably hospital-
acquired, although nosocomial listeriosis, to our
knowledge, has been described previously only in
outbreaks [15,29]. The diagnosis of nosocomial
foodborne listeriosis poses a problem because the
incubation period may be up to 1 month [30].
Therefore, the traditional criterion used to define
nosocomially acquired infections (i.e., hospitali-
sation for ‡ 3 days [31]) does not apply to listeri-
osis. All three patients in the present study with
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possible nosocomial infection had been hospital-
ised for > 1.5 months before developing infection.
The present study had some shortcomings.
First, the mortality of listeriosis may be somewhat
overestimated, as all deaths occurring within
1 month of the diagnosis of the infection were
considered to be related to listeriosis, unless
information was available that suggested an
initial favourable clinical response to treatment
in patients critically ill from an underlying dis-
ease. This possible overestimation relates only to
cases with predisposing conditions and immuno-
suppression. However, an association was only
found between a predisposing condition and an
increased CFR in the younger age group. This
association was robust and would be affected
only if the mortality rate was grossly overestima-
ted, which was not the case.
Second, the effect of antibiotic therapy was not
analysed, as information was limited for most
patients. Almost all patients were treated with
penicillin or ampicillin, often in combination with
an aminoglycoside, i.e., standard antibiotic ther-
apy for listeriosis [32]. The antibiotic susceptibil-
ity of Listeria has not changed in Denmark from
1958 to the present [33]. The initial therapy is
probably of utmost importance when considering
the risk of mortality, but this information was not
available for most patients.
In conclusion, the present study confirmed
the epidemiological relationships between list-
eriosis, clinical presentation, age and risk-factors
that have been reported previously. In addition,
the study found that infection with an isolate
belonging to serogroup 4 increases the CFR in
listeriosis, and that host-related risk-factors
known to predispose to disease also increase
the CFR in patients aged < 70 years; above this
age, the patient’s age is itself the most im-
portant risk-factor for death associated with
listeriosis.
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